Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|December 15, 2012
Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancerAntonija Kreso, Catherine A O'Brien, Peter van Galen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2018
Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal CancerJennifer Haynes, Trevor D McKee, Andrew Haller, et al.
Nature Communications|March 31, 2019
Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cellsEvelyne Lima-Fernandes, Alex Murison, Tiago da Silva Medina, et al.
Nature Medicine|December 3, 2013
Self-renewal as a therapeutic target in human colorectal cancerAntonija Kreso, Peter van Galen, Nicholas M Pedley, et al.
Science Translational Medicine|November 17, 2021
Assessing therapy response in patient-derived xenograftsJanosch Ortmann, Ladislav Rampášek, Elijah Tai, et al.
Nature Reviews. Cancer|September 2, 2024
Cancer drug-tolerant persister cells: from biological questions to clinical opportunitiesMariangela Russo, Mengnuo Chen, Elisa Mariella, et al.
Science Signaling|November 13, 2014
Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFRPeter J Belmont, Ping Jiang, Trevor D McKee, et al.
Cell|January 8, 2021
Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive ChemotherapySumaiyah K Rehman, Jennifer Haynes, Evelyne Collignon, et al.
Molecular Systems Biology|October 10, 2013
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilitiesFranco J Vizeacoumar, Roland Arnold, Frederick S Vizeacoumar, et al.
JAMA Oncology|April 12, 2019
Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical TrialErin D Kennedy, Marko Simunovic, Kartik Jhaveri, et al.
Pageof 3